Epigral (EPIGRAL) | Stock Overview & Key Data
Epigral Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹2,406.75 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Epigral
EPIGRAL
|
51.57B Mid-cap | -8.50% | -14.24% | 30.89% | -23.83% | -9.75% | -34.78% | 15.64% | 15.64% | 15.64% | 15.64% | 15.64% |
|
Navin Fluorine
NAVINFLUOR
|
322.36B Large-cap | -4.65% | 3.76% | 12.49% | 21.87% | 18.87% | 67.30% | 54.46% | 123.78% | 1,600.30% | 12,289.64% | 10,949.29% |
|
Deepak Nitrite
DEEPAKNTR
|
230.55B Large-cap | -2.35% | -3.76% | 9.10% | 10.62% | -0.87% | -17.03% | -19.39% | -2.87% | 1,957.49% | 8,856.34% | 9,344.13% |
|
Tata Chemicals
TATACHEM
|
176.61B Mid-cap | -5.84% | -8.40% | 3.89% | -6.55% | -1.74% | -14.56% | -21.84% | 1.59% | 300.80% | 360.37% | 674.42% |
|
Deepak Fertilisers
DEEPAKFERT
|
158.39B Mid-cap | -2.97% | 9.05% | 43.53% | 6.44% | 13.04% | -4.96% | 153.48% | 378.81% | 855.81% | 700.60% | 1,580.29% |
|
Archean Chemical
ACI
|
73.69B Mid-cap | -0.23% | -14.24% | -2.70% | 5.25% | -3.21% | -16.09% | -3.61% | -1.64% | -1.64% | -1.64% | -1.64% |
Ownership & Short Interest
Calculate Your Epigral Investment Returns
Long-Term Investment Performance Analysis
Epigral stock price in Aug 2023 was ₹1,003.85, A ₹1,000.00 lump sum investment in Epigral made 2 years ago would be worth approximately ₹1,125.87 today, representing a positive return of 12.59%. This translates to an annualized return (CAGR) of 4.38%.
2 Years 9 Months Investment Scenario (Aug 2023 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EPIGRAL's 52-week high and low?
- In the last 52 weeks, Epigral reached a high of ₹2,114.00 (on July 30, 2025) and a low of ₹807.00 (on March 30, 2026).
- What is the market cap and P/E ratio for EPIGRAL?
- Curious about Epigral's size and valuation? Its market capitalization stands at 51.57B. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.30, and the forward P/E (looking ahead) is 14.90.
- Does EPIGRAL pay dividends? If so, what's the yield?
- Yes, Epigral is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.64%, and the company has paid an average of ₹3.67 per share annually over the past 3 years.
- Who are Epigral's main competitors or similar companies to consider before investing?
When looking at Epigral, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Navin Fluorine
NAVINFLUOR322.36B Basic Materials Chemicals 67.30% 54.46% Deepak Nitrite
DEEPAKNTR230.55B Basic Materials Chemicals -17.03% -19.39% Tata Chemicals
TATACHEM176.61B Basic Materials Chemicals -14.56% -21.84% Deepak Fertilisers
DEEPAKFERT158.39B Basic Materials Chemicals -4.96% 153.48% Archean Chemical
ACI73.69B Basic Materials Chemicals -16.09% -3.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Epigral Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Epigral's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.78%, the Debt to Equity ratio from the most recent quarter is 25.57, and its Gross Profit Margin stands at 40.02%.
- What is the recent revenue and earnings growth for EPIGRAL?
- Looking at Epigral's growth, its revenue over the trailing twelve months (TTM) was INR24B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.50%, and quarterly earnings saw a YoY growth of -62.30%.
- How much of EPIGRAL stock is held by insiders and institutions?
- Wondering who owns Epigral stock? Company insiders (like executives and directors) hold about 68.86% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.82%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.